The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intranasal Drug and Vaccine Delivery Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Intranasal Drug and Vaccine Delivery Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Delivery devices for intranasal drugs and vaccines
This report is a detailed and comprehensive analysis for global Intranasal Drug and Vaccine Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Drug and Vaccine Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intranasal Drug and Vaccine Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intranasal Drug and Vaccine Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, GlaxoSmithKline, Teleflex, Intersect and Aptar Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Intranasal Drug and Vaccine Delivery Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder Conveyor
Liquid Delivery Device
Pressurized Metered Dose Inhaler
Other
Market segment by Application
Respiratory Diseases
Nervous System Disease
Vaccination
Pain Department
Other
Major players covered
Teva Pharmaceuticals
GlaxoSmithKline
Teleflex
Intersect
Aptar Pharma
3M
OptiNose
UCB
Bespak
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intranasal Drug and Vaccine Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intranasal Drug and Vaccine Delivery Devices, with price, sales, revenue and global market share of Intranasal Drug and Vaccine Delivery Devices from 2018 to 2023.
Chapter 3, the Intranasal Drug and Vaccine Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intranasal Drug and Vaccine Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intranasal Drug and Vaccine Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intranasal Drug and Vaccine Delivery Devices.
Chapter 14 and 15, to describe Intranasal Drug and Vaccine Delivery Devices sales channel, distributors, customers, research findings and conclusion.
The global Intranasal Drug and Vaccine Delivery Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Delivery devices for intranasal drugs and vaccines
This report is a detailed and comprehensive analysis for global Intranasal Drug and Vaccine Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Drug and Vaccine Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intranasal Drug and Vaccine Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intranasal Drug and Vaccine Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, GlaxoSmithKline, Teleflex, Intersect and Aptar Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Intranasal Drug and Vaccine Delivery Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder Conveyor
Liquid Delivery Device
Pressurized Metered Dose Inhaler
Other
Market segment by Application
Respiratory Diseases
Nervous System Disease
Vaccination
Pain Department
Other
Major players covered
Teva Pharmaceuticals
GlaxoSmithKline
Teleflex
Intersect
Aptar Pharma
3M
OptiNose
UCB
Bespak
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intranasal Drug and Vaccine Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intranasal Drug and Vaccine Delivery Devices, with price, sales, revenue and global market share of Intranasal Drug and Vaccine Delivery Devices from 2018 to 2023.
Chapter 3, the Intranasal Drug and Vaccine Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intranasal Drug and Vaccine Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intranasal Drug and Vaccine Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intranasal Drug and Vaccine Delivery Devices.
Chapter 14 and 15, to describe Intranasal Drug and Vaccine Delivery Devices sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Intranasal Drug and Vaccine Delivery Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Powder Conveyor
1.3.3 Liquid Delivery Device
1.3.4 Pressurized Metered Dose Inhaler
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Respiratory Diseases
1.4.3 Nervous System Disease
1.4.4 Vaccination
1.4.5 Pain Department
1.4.6 Other
1.5 Global Intranasal Drug and Vaccine Delivery Devices Market Size & Forecast
1.5.1 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity (2018-2029)
1.5.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Teva Pharmaceuticals
2.1.1 Teva Pharmaceuticals Details
2.1.2 Teva Pharmaceuticals Major Business
2.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product and Services
2.1.4 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Pharmaceuticals Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product and Services
2.2.4 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Teleflex
2.3.1 Teleflex Details
2.3.2 Teleflex Major Business
2.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Product and Services
2.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teleflex Recent Developments/Updates
2.4 Intersect
2.4.1 Intersect Details
2.4.2 Intersect Major Business
2.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Product and Services
2.4.4 Intersect Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Intersect Recent Developments/Updates
2.5 Aptar Pharma
2.5.1 Aptar Pharma Details
2.5.2 Aptar Pharma Major Business
2.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product and Services
2.5.4 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aptar Pharma Recent Developments/Updates
2.6 3M
2.6.1 3M Details
2.6.2 3M Major Business
2.6.3 3M Intranasal Drug and Vaccine Delivery Devices Product and Services
2.6.4 3M Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 3M Recent Developments/Updates
2.7 OptiNose
2.7.1 OptiNose Details
2.7.2 OptiNose Major Business
2.7.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Product and Services
2.7.4 OptiNose Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 OptiNose Recent Developments/Updates
2.8 UCB
2.8.1 UCB Details
2.8.2 UCB Major Business
2.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Product and Services
2.8.4 UCB Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 UCB Recent Developments/Updates
2.9 Bespak
2.9.1 Bespak Details
2.9.2 Bespak Major Business
2.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Product and Services
2.9.4 Bespak Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bespak Recent Developments/Updates
3 Competitive Environment: Intranasal Drug and Vaccine Delivery Devices by Manufacturer
3.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Manufacturer (2018-2023)
3.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intranasal Drug and Vaccine Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intranasal Drug and Vaccine Delivery Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Intranasal Drug and Vaccine Delivery Devices Manufacturer Market Share in 2022
3.5 Intranasal Drug and Vaccine Delivery Devices Market: Overall Company Footprint Analysis
3.5.1 Intranasal Drug and Vaccine Delivery Devices Market: Region Footprint
3.5.2 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Type Footprint
3.5.3 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region
4.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Region (2018-2029)
4.1.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Region (2018-2029)
4.2 North America Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
4.3 Europe Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
4.5 South America Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
5.2 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Type (2018-2029)
5.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
6.2 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Application (2018-2029)
6.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2018-2029)
7 North America
7.1 North America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
7.2 North America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
7.3 North America Intranasal Drug and Vaccine Delivery Devices Market Size by Country
7.3.1 North America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
8.2 Europe Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
8.3 Europe Intranasal Drug and Vaccine Delivery Devices Market Size by Country
8.3.1 Europe Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
10.2 South America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
10.3 South America Intranasal Drug and Vaccine Delivery Devices Market Size by Country
10.3.1 South America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Intranasal Drug and Vaccine Delivery Devices Market Drivers
12.2 Intranasal Drug and Vaccine Delivery Devices Market Restraints
12.3 Intranasal Drug and Vaccine Delivery Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Intranasal Drug and Vaccine Delivery Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intranasal Drug and Vaccine Delivery Devices
13.3 Intranasal Drug and Vaccine Delivery Devices Production Process
13.4 Intranasal Drug and Vaccine Delivery Devices Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intranasal Drug and Vaccine Delivery Devices Typical Distributors
14.3 Intranasal Drug and Vaccine Delivery Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
